Donald Trump caught a lot of heat for implying diversity, equity and inclusion programs could be at least partially to blame ...

“I understand the need for bipartisanship. I didn’t love the optics of you going to Mar-a-Lago,” she said to Fetterman as she referred to Trump’s home as a “palace.” “Overall, it was ...

The View's Ana Navarro criticized "the optics" of Sen. John Fetterman (D-PA) meeting with President Donald Trump at Mar-a-Lago. "I understand the need for bipartisanship. I didn’t love the ...

"I’m not suggesting any illegal person go voting illegally," Navarro said, before rolling her eyes.

D.C., Ana Navarro reacted to the contents of his address in a new “Behind the Table” segment with executive producer Brian Teta. Navarro was positively incensed over what Trump said at the ...

Navarro was positively incensed over what Trump said at the podium, including blaming diversity, equity, and inclusion initiatives (called DEI) for the fatal aircraft collision and citing only ...

Ozempic and other GLP-1 agonists are helping millions with weight loss but concerns grow over their long-term effects. Recent studies highlight side effects such as heart muscle weakening and skin ...

Novo estimates that CKD affects some 37 million adults in the U.S., with that number likely to rise in the coming years. The condition is also a common complication of Type 2 diabetes, cropping up ...

GLP-1 receptor agonist medications like Ozempic may do more than just change your waistline—they could influence how you shop at the grocery store. That’s the major takeaway from a new study ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is ...

Amy Schumer is no longer on the Ozempic train — for a good reason. On Wednesday, the “I Feel Pretty” star shared how she had a “horrible experience” taking the Type 2 diabetes drug ...

Ozempic becomes the first GLP-1 treatment option for people with type 2 diabetes and chronic kidney disease Mario Tama/Getty The Food and Drug Administration has approved Ozempic to reduce the ...